RALEIGH, N.C.--(BUSINESS WIRE)--Best-in-class commercial-grade technologies and equipment is being used for the first time in a pilot-scale training facility to train students in microbial fermentation and cell structure biotechnologies for the development of protein-based therapeutic drugs and commercial products. The facility, called the Biomanufacturing Training and Education Center, or BTEC, employs ABB’s Industrial IT System 800xA Extended Automation technology, instrumentation, analyzers and variable speed drives to achieve continuous validation and precise, real-time control of the bioreactors for real-time release under strictly maintained and regulated conditions.
